393 related articles for article (PubMed ID: 15791292)
1. Effect of BM 17.0744, a PPARalpha ligand, on the metabolism of perfused hearts from control and diabetic mice.
Aasum E; Cooper M; Severson DL; Larsen TS
Can J Physiol Pharmacol; 2005 Feb; 83(2):183-90. PubMed ID: 15791292
[TBL] [Abstract][Full Text] [Related]
2. Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
Carley AN; Semeniuk LM; Shimoni Y; Aasum E; Larsen TS; Berger JP; Severson DL
Am J Physiol Endocrinol Metab; 2004 Mar; 286(3):E449-55. PubMed ID: 14600074
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism.
Gilde AJ; van der Lee KA; Willemsen PH; Chinetti G; van der Leij FR; van der Vusse GJ; Staels B; van Bilsen M
Circ Res; 2003 Mar; 92(5):518-24. PubMed ID: 12600885
[TBL] [Abstract][Full Text] [Related]
4. Western diet impairs metabolic remodelling and contractile efficiency in cardiac hypertrophy.
Akki A; Seymour AM
Cardiovasc Res; 2009 Feb; 81(3):610-7. PubMed ID: 19028723
[TBL] [Abstract][Full Text] [Related]
5. Fenofibrate modulates cardiac and hepatic metabolism and increases ischemic tolerance in diet-induced obese mice.
Aasum E; Khalid AM; Gudbrandsen OA; How OJ; Berge RK; Larsen TS
J Mol Cell Cardiol; 2008 Jan; 44(1):201-9. PubMed ID: 17931655
[TBL] [Abstract][Full Text] [Related]
6. Metabolic effects of insulin on cardiomyocytes from control and diabetic db/db mouse hearts.
Carroll R; Carley AN; Dyck JR; Severson DL
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E900-6. PubMed ID: 15632103
[TBL] [Abstract][Full Text] [Related]
7. Glucose and insulin improve cardiac efficiency and postischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice.
Hafstad AD; Khalid AM; How OJ; Larsen TS; Aasum E
Am J Physiol Endocrinol Metab; 2007 May; 292(5):E1288-94. PubMed ID: 17213470
[TBL] [Abstract][Full Text] [Related]
8. Metabolic gene switching in the murine female heart parallels enhanced mitochondrial respiratory function in response to oxidative stress.
Essop MF; Chan WY; Taegtmeyer H
FEBS J; 2007 Oct; 274(20):5278-84. PubMed ID: 17892491
[TBL] [Abstract][Full Text] [Related]
9. Decreased contractile and metabolic reserve in peroxisome proliferator-activated receptor-alpha-null hearts can be rescued by increasing glucose transport and utilization.
Luptak I; Balschi JA; Xing Y; Leone TC; Kelly DP; Tian R
Circulation; 2005 Oct; 112(15):2339-46. PubMed ID: 16203912
[TBL] [Abstract][Full Text] [Related]
10. Angiotensin II downregulates the fatty acid oxidation pathway in adult rat cardiomyocytes via release of tumour necrosis factor-alpha.
Pellieux C; Montessuit C; Papageorgiou I; Lerch R
Cardiovasc Res; 2009 May; 82(2):341-50. PubMed ID: 19131364
[TBL] [Abstract][Full Text] [Related]
11. Chylomicron and palmitate metabolism by perfused hearts from diabetic mice.
Neitzel AS; Carley AN; Severson DL
Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E357-65. PubMed ID: 12397026
[TBL] [Abstract][Full Text] [Related]
12. Salacia oblonga root improves cardiac lipid metabolism in Zucker diabetic fatty rats: modulation of cardiac PPAR-alpha-mediated transcription of fatty acid metabolic genes.
Huang TH; Yang Q; Harada M; Uberai J; Radford J; Li GQ; Yamahara J; Roufogalis BD; Li Y
Toxicol Appl Pharmacol; 2006 Jan; 210(1-2):78-85. PubMed ID: 16129467
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator activated receptor alpha/gamma dual agonist tesaglitazar attenuates diabetic nephropathy in db/db mice.
Cha DR; Zhang X; Zhang Y; Wu J; Su D; Han JY; Fang X; Yu B; Breyer MD; Guan Y
Diabetes; 2007 Aug; 56(8):2036-45. PubMed ID: 17536062
[TBL] [Abstract][Full Text] [Related]
14. The effects of chronic trimetazidine treatment on mechanical function and fatty acid oxidation in diabetic rat hearts.
Onay-Besikci A; Guner S; Arioglu E; Ozakca I; Ozcelikay AT; Altan VM
Can J Physiol Pharmacol; 2007 May; 85(5):527-35. PubMed ID: 17632588
[TBL] [Abstract][Full Text] [Related]
15. Cardiac peroxisome proliferator-activated receptor-alpha activation causes increased fatty acid oxidation, reducing efficiency and post-ischaemic functional loss.
Hafstad AD; Khalid AM; Hagve M; Lund T; Larsen TS; Severson DL; Clarke K; Berge RK; Aasum E
Cardiovasc Res; 2009 Aug; 83(3):519-26. PubMed ID: 19398469
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of angiotensinogen in the myocardium induces downregulation of the fatty acid oxidation pathway.
Pellieux C; Aasum E; Larsen TS; Montessuit C; Papageorgiou I; Pedrazzini T; Lerch R
J Mol Cell Cardiol; 2006 Sep; 41(3):459-66. PubMed ID: 16859699
[TBL] [Abstract][Full Text] [Related]
17. Cardiac metabolism in mice: tracer method developments and in vivo application revealing profound metabolic inflexibility in diabetes.
Oakes ND; Thalén P; Aasum E; Edgley A; Larsen T; Furler SM; Ljung B; Severson D
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E870-81. PubMed ID: 16352676
[TBL] [Abstract][Full Text] [Related]
18. L-carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts.
Broderick TL; Panagakis G; DiDomenico D; Gamble J; Lopaschuk GD; Shug AL; Paulson DJ
Cardiovasc Res; 1995 Nov; 30(5):815-20. PubMed ID: 8595631
[TBL] [Abstract][Full Text] [Related]
19. Pomegranate flower improves cardiac lipid metabolism in a diabetic rat model: role of lowering circulating lipids.
Huang TH; Peng G; Kota BP; Li GQ; Yamahara J; Roufogalis BD; Li Y
Br J Pharmacol; 2005 Jul; 145(6):767-74. PubMed ID: 15880139
[TBL] [Abstract][Full Text] [Related]
20. Loss of stearoyl-CoA desaturase 1 inhibits fatty acid oxidation and increases glucose utilization in the heart.
Dobrzyn P; Sampath H; Dobrzyn A; Miyazaki M; Ntambi JM
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E357-64. PubMed ID: 18042664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
